Endovascular Treatment for eXtra-Large Ischemic Stroke

NCT06388148 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 286

Last updated 2025-12-26

No results posted yet for this study

Summary

The role of endovascular thrombectomy in patients with extra-large ischemic burden is still unclear. The XL STROKE-2 randomized trial is aiming to investigate the efficacy and safety of mechanical thrombectomy in acute extra-large ischemic stroke patients with large vessel occlusion.

Conditions

  • Stroke, Acute Ischemic

Interventions

DRUG

Medical management

Medical management includes IV thrombolysis, antiplatelet, and/or anticoagulation.

PROCEDURE

Endovascular thrombectomy

Endovascular thrombectomy with stent-retriever, local aspiration, angioplasty, and/or stenting.

Sponsors & Collaborators

  • The First Affiliated Hospital, University of South China

    collaborator UNKNOWN
  • Xiangtan Central Hospital

    collaborator OTHER
  • Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University

    collaborator UNKNOWN
  • Longyan First Affiliated Hospital of Fujian Medical University

    collaborator UNKNOWN
  • Taizhou First People's Hospital

    collaborator OTHER
  • Zhangzhou Affiliated Hospital of Fujian Medical University

    collaborator OTHER
  • Zhongming Qiu

    lead OTHER

Principal Investigators

  • Guangxiong Yuan · Xiangtan Central Hospital

  • Congguo Yin · Hangzhou First Hospital of Zhejiang University

  • Tingyu Yi · Zhangzhou Affiliated Hospital of Fujian Medical University

  • Chong Zheng · Longyan First Hospital of Fujian Medical University

  • Chenghua Xu · Taizhou First People's Hospital

  • Zhongfan Ruan · The First Affiliated Hospital, Hengyang Medical School, University of South China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-16
Primary Completion
2026-10-31
Completion
2027-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06388148 on ClinicalTrials.gov